FIELD: biotechnology, immunology, medicine.
SUBSTANCE: antigens for vaccine against influenza virus are prepared by preparing the crude viral concentrate and purification of viral concentrate is carried out by gel-filtration method on carrier "DIOL-500". Then viral concentrate is cleaved with detergent β-octylglucoside and vaccine antigens are isolated by gel-filtration method on carrier Sephadex G-50. Advantage of invention involves enhancing prophylactic properties of antigens of influenza viruses. Invention can be used in producing anti-influenza vaccine used in prophylaxis of influenza in population for aim reducing risk and complications of the disease.
EFFECT: improved preparing method.
6 tbl
Title | Year | Author | Number |
---|---|---|---|
INACTIVATED SPLIT INFLUENZA VACCINE AND PREPARATION METHOD THEREOF | 2015 |
|
RU2584594C1 |
METHOD OF PRODUCING ANTIGEN OR ANTIGENS FOR PRODUCTION OF INFLUENZA VACCINE AND A VACCINE BASED ON IT | 2019 |
|
RU2710239C1 |
METHOD FOR OBTAINING A TETRAVALENT VACCINE FOR THE PREVENTION OF INFLUENZA | 2020 |
|
RU2754398C1 |
METHOD FOR PRODUCTION OF TETRAVALENT SUBUNIT VACCINE AGAINST INFLUENZA WITHOUT ADJUVANTS | 2020 |
|
RU2741003C1 |
METHOD OF PREPARING INFLUENZA VACCINE | 2009 |
|
RU2423995C1 |
PENTAVALENT SUBUNIT VACCINE AGAINST RESPIRATORY INFECTIONS AND METHOD OF ITS PREPARATION | 2022 |
|
RU2804948C2 |
METHOD OF PRODUCING TETRAVALENT SUBUNIT INFLUENZA VACCINE | 2019 |
|
RU2740751C1 |
INFLUENZA VACCINE AND METHOD FOR PREPARING IT | 2010 |
|
RU2446824C2 |
TEST SYSTEM FOR DETERMINING SPECIFIC ACTIVITY OF INFLUENZA VIRUS AND METHOD FOR ITS OBTAINING | 2022 |
|
RU2804067C1 |
METHOD FOR PREPARING HIGH-PURITY VIRION CONCENTRATE | 2013 |
|
RU2535153C1 |
Authors
Dates
2006-09-10—Published
2005-03-21—Filed